Repligen (RGEN) Tops Q1 EPS by 2c; Raises Outlook

Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.12, $0.02 better than the analyst estimate of $0.10. Revenue for the quarter came in at $25.1 million versus the consensus estimate of $22.54 million.

Tony J. Hunt, President and Chief Executive Officer, said, “Our record revenue during the first quarter reflects overall growth of 21% year-over-year, driven by increased demand for our proprietary products, which we believe is a direct result of our commercial expansion in 2015. We continue to add best-in-class technologies to our portfolio, and we closed out the quarter by executing on our acquisition strategy with our April 1st purchase of Atoll GmBH (“Atoll”). We are pleased with how the integration is progressing and look forward to establishing the Weingarten, Germany, facility as our European customer-facing center for many of our high-value products.”

GUIDANCE:

Repligen sees FY2016 EPS of $0.45-$0.51, versus the consensus of $0.43. Repligen sees FY2016 revenue of $98-102 million, versus prior guidance of $93-96 million and the consensus of $96.77 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c